OBJECTIVE: This study aimed to determine whether an anti-inflammatory profile in meningococcal disease is associated with an increased risk of severe disease or septic shock. DESIGN AND SETTING: Prospective observational study in a tertiary care children's hospital. PATIENTS AND PARTICIPANTS: 63 children with confirmed meningococcal disease. INTERVENTIONS: Plasma concentrations of interleukin-1 receptor antagonist (IL-1Ra), interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF) were assayed on admission. Receiver operator characteristic curve analysis was used to determine optimum thresholds for IL-1Ra:TNF, IL-1Ra:IL-6 and IL-1Ra:IL-8 ratios. MEASUREMENTS AND RESULTS: Median IL-1Ra:TNF and IL-1Ra:IL-6 ratios were significantly higher in severe disease with septic shock than in severe disease without septic shock and in non severe disease (IL-1Ra:TNF 263 vs. 185 vs. 108; IL-1Ra:IL-6 139 vs. 23 vs. 17). Median IL-1Ra:IL-8 ratios were not significantly different in the three groups. A significantly larger proportion of children with high IL-1Ra:TNF-alpha and IL-1Ra:IL-6 ratios developed severe disease with septic shock than those with a low ratios (95.2% vs. 4.8%; 76.2% vs. 23.8%). CONCLUSIONS: An anti-inflammatory profile appears to be associated with the development of severe disease and septic shock in meningococcal sepsis. This may imply that experimental new therapies of pro-inflammatory cytokine inhibition and anti-inflammatory cytokines in meningococcal disease could be detrimental.
OBJECTIVE: This study aimed to determine whether an anti-inflammatory profile in meningococcal disease is associated with an increased risk of severe disease or septic shock. DESIGN AND SETTING: Prospective observational study in a tertiary care children's hospital. PATIENTS AND PARTICIPANTS: 63 children with confirmed meningococcal disease. INTERVENTIONS: Plasma concentrations of interleukin-1 receptor antagonist (IL-1Ra), interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF) were assayed on admission. Receiver operator characteristic curve analysis was used to determine optimum thresholds for IL-1Ra:TNF, IL-1Ra:IL-6 and IL-1Ra:IL-8 ratios. MEASUREMENTS AND RESULTS: Median IL-1Ra:TNF and IL-1Ra:IL-6 ratios were significantly higher in severe disease with septic shock than in severe disease without septic shock and in non severe disease (IL-1Ra:TNF 263 vs. 185 vs. 108; IL-1Ra:IL-6 139 vs. 23 vs. 17). Median IL-1Ra:IL-8 ratios were not significantly different in the three groups. A significantly larger proportion of children with high IL-1Ra:TNF-alpha and IL-1Ra:IL-6 ratios developed severe disease with septic shock than those with a low ratios (95.2% vs. 4.8%; 76.2% vs. 23.8%). CONCLUSIONS: An anti-inflammatory profile appears to be associated with the development of severe disease and septic shock in meningococcal sepsis. This may imply that experimental new therapies of pro-inflammatory cytokine inhibition and anti-inflammatory cytokines in meningococcal disease could be detrimental.
Authors: M van Deuren; J van der Ven-Jongekrijg; P N Demacker; A K Bartelink; R van Dalen; R W Sauerwein; H Gallati; J L Vannice; J W van der Meer Journal: J Infect Dis Date: 1994-01 Impact factor: 5.226
Authors: M van Deuren; J van der Ven-Jongekrijg; A K Bartelink; R van Dalen; R W Sauerwein; J W van der Meer Journal: J Infect Dis Date: 1995-08 Impact factor: 5.226
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker Journal: Intensive Care Med Date: 2006-02-18 Impact factor: 17.440
Authors: Deana N Toussi; Margaretha Carraway; Lee M Wetzler; Lisa A Lewis; Xiuping Liu; Paola Massari Journal: Infect Immun Date: 2012-07-23 Impact factor: 3.441
Authors: Noortje de Haan; Navin P Boeddha; Ebru Ekinci; Karli R Reiding; Marieke Emonts; Jan A Hazelzet; Manfred Wuhrer; Gertjan J Driessen Journal: MBio Date: 2018-06-19 Impact factor: 7.867
Authors: Joel Fleury Djoba Siawaya; Teri Roberts; Chantal Babb; Gillian Black; Hawa Jande Golakai; Kim Stanley; Nchinya Bennedict Bapela; Eileen Hoal; Shreemanta Parida; Paul van Helden; Gerhard Walzl Journal: PLoS One Date: 2008-07-02 Impact factor: 3.240